Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Meta Platforms Inc (META) vs Teladoc Health Inc (TDOC) Price & Performance

Meta Platforms IncTrade
Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

Meta Platforms Inc vs Teladoc Health Inc — how do they compare? Meta Platforms Inc trades at $599.83 (market cap $1.52T), while Teladoc Health Inc trades at $6.85 (market cap $1.29B). The key difference: Meta Platforms Inc is far larger — about 1178.3× Teladoc Health Inc's market cap, and Meta Platforms Inc pays a 0.35% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.

METATDOC
Market Cap
$1.52T$1.29B
Volume
24,093,972
Sector
MediaHealth
52-Week High
$790.00$9.72
52-Week Low
$525.72$4.47
Enterprise Value
$1.54T$1.55B
Dividend Yield
0.35%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Meta Platforms Inc

META stock trades at $594.92, up 0.48% over 24 hours, with a bearish technical signal driven by moving averages and overbought short-term RSI. The company reported strong Q1 2026 earnings of $10.44 EPS, beating expectations, but missed in Q2 2026. Revenue growth remains robust, with 2025 revenue at $200.97 billion, though net income dipped to $60.46 billion. Recent news highlights the launch of AI model Muse Spark and a legal ruling in Massachusetts over youth addiction claims.

Outlook is mixed: analyst consensus is bullish with a $761.95 price target, citing AI innovations and solid fundamentals, but risks include high capital expenditure, regulatory lawsuits, and competitive pressures. The stock's valuation metrics like P/E of 22.41 suggest room for growth if execution continues, but investors should weigh legal and market volatility concerns.

Teladoc Health Inc

TDOC trades at $7.13, up 6.74% in the last session, but remains under pressure after a 28% drop in August 2026 due to a revenue miss and lowered guidance. The stock shows oversold technical signals with RSI near 24, while fundamentals reveal a net loss margin of -7.13% despite a gross margin of 68.97%. Recent news highlights multiple law firm investigations into securities claims, adding to investor uncertainty.

The outlook is cautious; analyst consensus is a hold with a $8.88 price target, but risks include ongoing losses, competitive pressures, and legal scrutiny. Upside depends on execution in integrated care, but near-term volatility is high.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Meta Platforms Inc

Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.

Read more on META

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC